Taher Nassar

Title: The Innovative Contributions of Taher Nassar

Introduction

Taher Nassar is a prominent inventor based in Kfar Tur'an, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel drug compounds. With a total of 5 patents to his name, Nassar's work is recognized for its potential impact on cancer therapy and other medical applications.

Latest Patents

Nassar's latest patents include groundbreaking inventions such as CB1R receptor blockers with acyclic backbones. This invention concerns a novel class of CB1 receptor binding molecules and their various uses. Another notable patent involves Pt (IV) derivatives and nanocarriers comprising them. This patent provides Pt (IV) lipophilic derivatives aimed at improving drug performance in cancer therapy, along with the nanocarriers that include these derivatives.

Career Highlights

Taher Nassar is affiliated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this esteemed institution has allowed him to explore innovative solutions in drug development and delivery systems. Nassar's research is characterized by a commitment to enhancing therapeutic efficacy and patient outcomes.

Collaborations

Throughout his career, Nassar has collaborated with notable colleagues, including Simon Benita and Abraham Rubinstein. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further advancing the field of pharmaceutical research.

Conclusion

Taher Nassar's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his role as a key figure in medical research. His work continues to pave the way for advancements in cancer therapy and drug development.